Company / Current Liabilities
Apogee Therapeutics, Inc. Current Liabilities History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$28.6M
FY2024
5-year range
$10.0M / $28.6M
FY2022-FY2024
Trend
+38.9%
vs FY2023
Sector context
#178 of 213
Health Care
What the data says
Apogee Therapeutics, Inc.'s current liabilities of $29M is lower than 84% of companies in the Health Care sector (FY2024). Increased from $10M to $29M over the past 2 years.
Based on SEC 10-K filings.
$29M in FY2024.
Increased from $10M to $29M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 213This company $28.6M Sector average $1.6B
▼
-98.2% below sector average
Key checks
Key Insights
- In FY2024, current liabilities increased 38.9% year-over-year.
- Ranks #178 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $28.6M | +38.9% |
| FY2023 | $20.6M | +106.0% |
| FY2022 | $10.0M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026